Lv4
440 积分 2025-04-04 加入
Sphingosine-1-phosphate and vascular disease in the general population
3天前
待确认
argeting PCSK9 beyond the liver: evidence from experimental and clinical studies
4天前
已完结
Exploring the Pleiotropy of PCSK9: A Wide Range of Influences from Lipid Regulation to Extrahepatic Function
4天前
已关闭
Embelin Elevates Endoplasmic Reticulum Calcium Levels and Blocks the Sterol Regulatory Element-Binding Protein 2 Mediated Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Improves the Low-Density Lipoprotein Receptor Mediated Lipid Clearance on Hepatocytes
4天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
4天前
已完结
Low-density lipoprotein cholesterol goal attainment and mortality in ischaemic heart disease: a two-year observational study
4天前
已关闭
Long-Term Lipid Lowering With Evolocumab in Older Individuals
4天前
已完结
2024 consensus document of the Italian Society of Arterial Hypertension (SIIA) and the Italian Society of Cardiovascular Prevention (SIPREC): update on LDL cholesterol lowering in patients with arterial hypertension
4天前
已完结
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering
4天前
已完结
The interplay of LDLR, PCSK9, and lncRNA- LASER genes expression in coronary artery disease: Implications for therapeutic interventions
4天前
已完结
皖公网安备34019202002308
